Idaho state Sen. Brandon Shippy, R-New Plymouth proposed a bill that would ban COVID vaccines, and others created with memory ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

During the COVID-19 pandemic, health worker Maria Tereza Malheiros Sapienza's curiosity was aroused by her immunity to ...

The same mechanisms involved in COVID-related cardiovascular events are responsible for COVID-related myocarditis.

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

Researchers have identified two microRNA that may predict which individuals with cancer are at elevated risk for COVID-19-related death.Low levels of hsa-miR-150-5p and hsa-miR-93-5p in COVID-19 ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who ...

Arcturus Therapeutics Holdings Inc.’s ARCT share price has surged by 11.71%, which has investors questioning if this is right ...